APS

30th APS Annual Convention · 2018

Neuropsychological Prediction of Treatment Response to Ketamine in Patients with Suicidal Ideation and Major Depression

San Francisco, CA · May 2018

Poster · Clinical Science

  • Sean Madden
    Columbia University Department of Psychiatry
  • Sean Madden
    New York State Psychiatric Institute
  • John Keilp
    Columbia University Vagelos College of Physicians and Surgeons
  • John Keilp
    New York State Psychiatric Institute
  • Michael Grunebaum
    Columbia University Department of Psychiatry
  • Michael Grunebaum
    New York State Psychiatric Institute
  • Julia Marver
    Columbia University Department of Psychiatry
  • Julia Marver
    New York State Psychiatric Institute
  • Michelle Parris
    Columbia University Department of Psychiatry
  • Michelle Parris
    New York State Psychiatric Institute
  • Maria Oquendo
    University of Pennsylvania Perelman School of Medicine
  • J. Mann
    Columbia University Department of Psychiatry
  • J. Mann
    New York State Psychiatric Institute

Abstract

Seventy-eight depressed patients with elevated suicidal ideation receiving ketamine vs. midazolam infusion as an antidepressant treatment completed neuropsychological assessments. Better baseline memory performance predicted ketamine antidepressant response, contrasting with previous studies; less implicit association to suicide and lower risk taking were associated with reductions in suicidal thinking.

Depression

← Poster Session XVIII